What's Going On With Leap Therapeutics Stock On Thursday?

Benzinga11-13

Leap Therapeutics, Inc. (NASDAQ:LPTX) slid in premarket trading on Thursday after unveiling significant corporate changes and a large at-the-market equity plan. The biotechnology company is rebranding...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583359417?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/13/Leap-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=260","is_english":true,"pubTime":"2025-11-13 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583359417","market":"us","top_or_hot":-1,"title":"What's Going On With Leap Therapeutics Stock On Thursday?","media":"Benzinga","content":"<div>\n<p>Leap Therapeutics, Inc. (NASDAQ:LPTX) slid in premarket trading on Thursday after unveiling significant corporate changes and a large at-the-market equity plan.\nThe biotechnology company is rebranding...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/25/11/48835777/whats-going-on-with-leap-therapeutics-stock-on-thursday\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's Going On With Leap Therapeutics Stock On Thursday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's Going On With Leap Therapeutics Stock On Thursday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-13 23:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/25/11/48835777/whats-going-on-with-leap-therapeutics-stock-on-thursday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Leap Therapeutics, Inc. (NASDAQ:LPTX) slid in premarket trading on Thursday after unveiling significant corporate changes and a large at-the-market equity plan.\nThe biotechnology company is rebranding...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/25/11/48835777/whats-going-on-with-leap-therapeutics-stock-on-thursday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/25/11/48835777/whats-going-on-with-leap-therapeutics-stock-on-thursday","article_id":"2583359417","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/13/Leap-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/11/48835777/whats-going-on-with-leap-therapeutics-stock-on-thursday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2583359417","pubTimestamp":1763046120,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Leap Therapeutics shares are plunging after rebranding as Cypherpunk, pivoting to a Zcash treasury and announcing a $200M stock offering.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","BK4539":"次新股","BK4563":"昨日强势股","BK4505":"高瓴资本持仓","BK4007":"制药"},"translate_title":"周四Leap Therapeutics股票发生了什么？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LPTX":1,"LENZ":1.5},"content_text":"Leap Therapeutics, Inc. (NASDAQ:LPTX) slid in premarket trading on Thursday after unveiling significant corporate changes and a large at-the-market equity plan.\nThe biotechnology company is rebranding as Cypherpunk Technologies Inc. to pivot toward a digital-asset-focused strategy, per a press release issued yesterday.\nThe company stated that it is adopting the Cypherpunk name and shifting to a digital-asset treasury anchored in Zcash. The ticker will change from LPTX to CYPH on Nov. 13, 2025, following the rebrand and adoption of the digital-asset treasury strategy.\nAlso Read: Government Shutdown Over—But Bitcoin Remains In ‘Extreme Fear’ At $103,000\nLeadership said it has already deployed $50 million to acquire more than 203,000 ZEC at an average price of $245 each. The stock will begin trading under the ticker CYPH on Thursday as part of the transition.\nMeanwhile, on Thursday, Leap Therapeutics detailed a new sales agreement that allows it to sell up to $200 million in stock through Cantor Fitzgerald. The firm disclosed terms of the arrangement in its latest filing, marking another step in its strategic overhaul.\nThe company, which posted a narrower third-quarter loss on Wednesday, reported an eight-cent-per-share loss. It also sharply reduced its net loss from a year earlier after cutting research, development and administrative expenses.\nCash stood at nearly $10 million at the end of September, excluding funds from a recent private placement.\nThe firm appointed Khing Oei as chairman and added Will McEvoy as its first chief investment officer. Both joined the board this week following the company's $58.88 million private placement led solely by Winklevoss Capital.\nExecutives described the digital-asset strategy as a long-term effort centered on privacy and shareholder value.\nPrice Action: LPTX shares are trading 23.9% lower at $1.55 premarket at last check on Thursday.\nRead Next:\nPhoto: Shutterstock","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583359417","isCrawlerRequest":true}